Casdin Partners Master Fund, L.P.

CIK 1534265
Transactions on file
44
Open-market buys
30
Win rate (buys)
13%
30 scored
Avg % since filing (buys)
-21.3%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-06-082026-06-05WGS
GeneDx Holdings Corp.
Director10%
Buy50,000$2.64M+6.6%open →
2026-06-082026-06-04WGS
GeneDx Holdings Corp.
Director10%
Buy150,000$8.47M-0.2%open →
2026-05-212026-05-21BLFS
BIOLIFE SOLUTIONS INC
10%
Sale650,000$15.40M+16.2%open →
2026-05-212026-05-20BLFS
BIOLIFE SOLUTIONS INC
10%
Sale250,000$5.92M+16.2%open →
2026-05-212026-05-19BLFS
BIOLIFE SOLUTIONS INC
10%
Sale300,000$6.79M+21.6%open →
2026-05-202026-05-20WGS
GeneDx Holdings Corp.
Director10%
Buy140,000$6.13M+28.6%open →
2026-05-202026-05-19WGS
GeneDx Holdings Corp.
Director10%
Buy185,000$7.88M+32.2%open →
2026-05-202026-05-18WGS
GeneDx Holdings Corp.
Director10%
Buy175,000$7.45M+32.4%open →
2025-03-042025-02-28LAB
STANDARD BIOTOOLS INC.
Director10%
Grant58,215$62.3K-17.2%open →
2025-03-042025-02-28LAB
STANDARD BIOTOOLS INC.
Director10%
Buy4,820,959$5.16M-17.2%open →
2025-03-042025-02-28LAB
STANDARD BIOTOOLS INC.
Director10%
Other545,000$583.1K-17.2%open →
2025-03-042025-02-28LAB
STANDARD BIOTOOLS INC.
Director10%
Other545,000$583.1K-17.2%open →
2025-04-092025-04-07BLFS
BIOLIFE SOLUTIONS INC
10%
Other27,994open →
2025-05-152025-05-13TSVT
2seventy bio, Inc.
Director
U2,000,000$10.00Mopen →
2025-05-152025-05-13TSVT
2seventy bio, Inc.
Director
U22,625$113.1Kopen →
2025-06-122025-06-10BLFS
BIOLIFE SOLUTIONS INC
10%
Sale1,000,000$23.80M+15.8%open →
2025-12-042025-12-04LAB
STANDARD BIOTOOLS INC.
Director10%
Buy150,000$217.0K-38.7%open →
2025-12-042025-12-03LAB
STANDARD BIOTOOLS INC.
Director10%
Buy75,000$108.0K-38.5%open →
2025-12-042025-12-02LAB
STANDARD BIOTOOLS INC.
Director10%
Buy125,000$177.5K-37.6%open →
2025-11-262025-11-25LAB
STANDARD BIOTOOLS INC.
Director10%
Buy7,550,000$9.84M-32.0%open →
2025-11-262025-11-24LAB
STANDARD BIOTOOLS INC.
Director10%
Buy150,000$214.9K-38.1%open →
2025-11-202025-11-20LAB
STANDARD BIOTOOLS INC.
Director10%
Buy450,000$586.3K-32.0%open →
2025-11-202025-11-19LAB
STANDARD BIOTOOLS INC.
Director10%
Buy350,000$448.9K-30.9%open →
2025-11-202025-11-18LAB
STANDARD BIOTOOLS INC.
Director10%
Buy275,000$339.4K-28.2%open →
2025-11-172025-11-17LAB
STANDARD BIOTOOLS INC.
Director10%
Buy225,000$275.6K-27.6%open →
2025-11-172025-11-14LAB
STANDARD BIOTOOLS INC.
Director10%
Buy250,000$309.8K-28.5%open →
2025-11-172025-11-13LAB
STANDARD BIOTOOLS INC.
Director10%
Buy450,000$541.4K-26.3%open →
2025-11-122025-11-12LAB
STANDARD BIOTOOLS INC.
Director10%
Buy375,000$445.8K-25.5%open →
2025-11-122025-11-11LAB
STANDARD BIOTOOLS INC.
Director10%
Buy300,000$358.8K-25.9%open →
2025-11-122025-11-10LAB
STANDARD BIOTOOLS INC.
Director10%
Buy275,000$321.9K-24.3%open →
2025-11-122025-11-07LAB
STANDARD BIOTOOLS INC.
Director10%
Buy225,000$252.8K-21.1%open →
2025-10-172025-10-15BLFS
BIOLIFE SOLUTIONS INC
10%
Sale750,000$21.41M-3.5%open →
2025-08-132025-08-11BLFS
BIOLIFE SOLUTIONS INC
10%
Sale500,000$11.30M+21.9%open →
2025-08-152025-08-15LAB
STANDARD BIOTOOLS INC.
Director10%
Buy150,000$183.0K-27.4%open →
2025-08-152025-08-14LAB
STANDARD BIOTOOLS INC.
Director10%
Buy133,220$161.2K-26.8%open →
2025-08-152025-08-13LAB
STANDARD BIOTOOLS INC.
Director10%
Buy75,000$98.3K-32.4%open →
2025-08-212025-08-15BLFS
BIOLIFE SOLUTIONS INC
10%
Sale500,000$12.20M+12.9%open →
2025-08-222025-08-22WGS
GeneDx Holdings Corp.
Director10%
Sale500,000$60.45M-53.4%open →
2025-08-262025-08-26LAB
STANDARD BIOTOOLS INC.
Director10%
Buy125,000$157.5K-29.7%open →
2025-08-262025-08-22LAB
STANDARD BIOTOOLS INC.
Director10%
Buy200,000$252.0K-29.7%open →
2025-08-262025-08-25LAB
STANDARD BIOTOOLS INC.
Director10%
Buy200,000$248.0K-28.5%open →
2025-09-052025-09-03LAB
STANDARD BIOTOOLS INC.
Director10%
Buy250,000$317.5K-30.2%open →
2025-09-052025-09-04LAB
STANDARD BIOTOOLS INC.
Director10%
Buy250,000$320.0K-30.8%open →
2025-09-112025-09-09LAB
STANDARD BIOTOOLS INC.
Director10%
Buy100,000$129.0K-31.3%open →